Stock Message Board Recent Posts http://investorshangout.com/search?q=AZNCF&am...mp;yt0=Go!
Last Updated: 11/16/2014 16:36:17
Current Price and Quotes
Last Price 72.55
Previous Close 74.10 Open 72.55
Daily Range 72.55 - 72.55 52wk Range 52.95 - 81.70
Volume 196 Dividend N/A
Average Vol (30d) 2,029 Yield N/A
Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 25,711,000 27,973,000 33,591,000 33,269,000
Cost of Revenue 5,261,000 5,393,000 6,026,000 6,389,000
Gross Profit 20,450,000 22,580,000 27,565,000 26,880,000
Operating Expenses
Research and Development 4,821,000 5,243,000 5,523,000 5,318,000
Sales, General and Admin. 11,917,000 9,189,000 10,730,000 10,068,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 3,712,000 8,148,000 12,795,000 11,494,000
Income From Continuing Operations
Add'l Income/Expense Items 50,000 42,000 1,533,000 516,000
Earnings Before Interest and Tax 3,762,000 8,190,000 12,845,000 12,010,000
Interest Expense 495,000 544,000 562,000 1,033,000
Earnings Before Tax 3,267,000 7,646,000 12,283,000 10,977,000
Income Tax 696,000 1,376,000 2,333,000 2,896,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 2,571,000 6,270,000 9,950,000 8,081,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 2,571,000 6,270,000 9,950,000 8,081,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 2,571,000 6,270,000 9,950,000 8,081,000
Recent News
Source
Nov 16, 2014 AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting BUSINESS WIRE
Nov 14, 2014 FibroGen Looks Healthy Heading Into IPO Seeking Alpha
Nov 14, 2014 Cramer sees Dow Chemical in "smart, aggressive buyback" Seeking Alpha
Nov 13, 2014 AstraZeneca Announces Initiation of Development Program for BRILINTA (ticagrelor) Reversal Agent BUSINESS WIRE
Nov 13, 2014 BIND Therapeutics Offers Great Potential With Upcoming Catalyst Seeking Alpha
Nov 12, 2014 Advaxis submits IND for HPV-associated cancers Seeking Alpha
Nov 11, 2014 Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis PR NEWSWIRE
Nov 11, 2014 Amgen's brodalumab beats Stelara in Phase 3 trial Seeking Alpha
Nov 11, 2014 Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk PR NEWSWIRE
Nov 11, 2014 Re-Examining My Bullish Thesis On Walgreen Seeking Alpha
1
2
3
4
5
next >
AZNCF AstraZeneca Plc Research DD Guide
Stock Message Board http://investorshangout.com/search?q=AZNCF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/AZNCF/quote
Stock Chart http://www.otcmarkets.com/stock/AZNCF/chart
Company Info http://www.otcmarkets.com/stock/AZNCF/company-info
Recent News http://www.otcmarkets.com/stock/AZNCF/news
Financials http://www.otcmarkets.com/stock/AZNCF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/AZNCF/filings
Short Sales http://www.otcmarkets.com/stock/AZNCF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/AZNCF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/AZNCF/research
Summary http://finance.yahoo.com/q?s=AZNCF
Historical Prices http://finance.yahoo.com/q/hp?s=AZNCF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=AZNCF
Basic Chart http://finance.yahoo.com/q/bc?s=AZNCF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AZNCF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=AZNCF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=AZNCF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=AZNCF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=AZNCF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=AZNCF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=AZNCF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=AZNCF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=AZNCF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=AZNCF
Balance Sheet http://finance.yahoo.com/q/bs?s=AZNCF
Cash Flow http://finance.yahoo.com/q/cf?s=AZNCF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/AZNCF
Market Watch http://www.marketwatch.com/investing/stock/AZNCF
Bloomberg http://www.bloomberg.com/quote/AZNCF:US
Morningstar http://quotes.morningstar.com/stock/s?t=AZNCF
Bussinessweek http://investing.businessweek.com/research/st...cker=AZNCF
Barchart http://www.barchart.com/quotes/stocks/AZNCF
OTC Short Report http://otcshortreport.com/index.php?index=AZNCF
Investopedia http://www.investopedia.com/markets/stocks/AZNCF/?wa=0